Is the use of Ro 10-9359 (Tigason) in children justified?
作者信息
van der Rhee H J, van Gelderen H H, Polano M K
出版信息
Acta Derm Venereol. 1980;60(3):274-5.
PMID:6158237
Abstract
In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.
摘要
Zotero 插件